Qube Research & Technologies (QRT)’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-158,235
Closed -$1.42M 3986
2025
Q4
$1.42M Buy
+158,235
New +$2.18M ﹤0.01% 2408
2025
Q2
Sell
-49,324
Closed -$351K 3888
2025
Q1
$351K Sell
49,324
-432,243
-90% -$4.37M ﹤0.01% 2681
2024
Q4
$5.62M Buy
481,567
+292,634
+155% +$4.57M 0.01% 1422
2024
Q3
$3.88M Buy
+188,933
New +$4.36M 0.01% 1509
2024
Q2
Sell
-44,588
Closed -$1.23M 4454
2024
Q1
$1.23M Sell
44,588
-196,103
-81% -$5.45M ﹤0.01% 2027
2023
Q4
$7.34M Buy
240,691
+195,432
+432% +$5.62M 0.02% 862
2023
Q3
$1.43M Sell
45,259
-24,481
-35% -$950K ﹤0.01% 1561
2023
Q2
$2.84M Buy
69,740
+46,774
+204% +$1.9M 0.01% 905
2023
Q1
$856K Sell
22,966
-1,869
-8% -$73.3K ﹤0.01% 1355
2022
Q4
$866K Buy
+24,835
New +$1.18M 0.01% 1283
2022
Q2
Sell
-16,572
Closed -$1.2M 2933
2022
Q1
$1.2M Buy
+16,572
New +$1.4M 0.01% 1070
2021
Q4
Sell
-1,652
Closed -$222K 2837
2021
Q3
$222K Sell
1,652
-16,932
-91% -$2.56M ﹤0.01% 1611
2021
Q2
$3.01M Buy
+18,584
New +$1.45M 0.04% 564

Other funds holding NTLA